NRx Pharmaceuticals Inc (NRXPW) — Cash Flow Quality Index

Latest as of December 2025: -10.31x

NRx Pharmaceuticals Inc (NRXPW) has a Cash Flow Quality Index of -10.31x as of December 2025. Operating cash flow of $-3.71 Million is below net income of $360.00K, suggesting accrual-heavy earnings not yet converted to cash. Explore NRx Pharmaceuticals Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-10.31x
Operating CF / Net Income

Operating Cash Flow

$-3.71 Million
USD

Net Income

$360.00K
USD

Data as of

Dec 2025
Most recent filing

NRx Pharmaceuticals Inc Cash Flow Quality Index (2018–2019)

Historical Cash Flow Quality Index for NRx Pharmaceuticals Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash flow conversion of NRx Pharmaceuticals Inc.

Annual Cash Flow Quality Index for NRx Pharmaceuticals Inc (2018–2019)

Year-by-year earnings quality comparison for NRx Pharmaceuticals Inc.

Year Quality Index Operating CF (USD) Net Income YoY Change
2019 -1.94x $-792.73K $408.43K ▲ +72.9%
2018 -7.16x $-473.19K $66.10K
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.